Table 5.

Patients with cardiological AES (5%) in the R-CHOP and R-B groups.

Patient No.	Gender	CTCAE	Therapy	BMI	Apex Delta (HU)	Ant. Sulcus Delta (HU)	Post. Sulcus Delta (HU)	EF Delta (%)	ECV Delta	EF Delta (%)
1	F	Atrial fibrillation (AF)	R-CHOP	22.8	−12	−23	−21	−56	0.21	−13
2	F	Heart failure	R-CHOP	21.8	−9	−10	−14	−33	0.15	−6
3	M	Heart failure	R-CHOP	22.5	−10	−12	−10	−32	0.22	−12
4	F	Arterial thromboembolism	R-bendamustine	20.9	0	−2	−2	−4	0.10	0

CTCAE: common terminology criteria for adverse events; BMI: body mass index; ECV: myocardial extracellular volume; HU: Hounsfield unit; EF: ejection fraction.